Other News To Note
• Anida Pharma Inc., of Cambridge, Mass., said it was awarded funding from the Michael J. Fox Foundation for Parkinson’s Research to conduct preclinical research using its lead compound for neurodegenerative diseases, Neuroprotectin D1, an endogenous DHA-derived lipid mediator that regulates circuits of resolution.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter